A Study of RO7830698 in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease

StatusRecruiting
PhasePhase 1/2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened
    • Study sites: 0 to 1
  2. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Roche/Genentech
368 trials monitored
See 30 trials at risk
COPD
1,120 trials monitored
See 35 trials at risk
This study will evaluate the safety, tolerability, pharmacokinetics (PK), immunogenicity, and pharmacodynamics (PD) of single and multiple doses of RO7830698 in healthy participants and participants with chronic obstructive pulmonary disease (COPD).
Trial Details
NCT Number NCT07822334
Lead Sponsor Hoffmann-La Roche
Conditions
(from sponsor)		 Chronic Obstructive Pulmonary Disease (COPD), Healthy Participants
Related terms Pulmonary Disease, Chronic Obstructive
Enrollment 104 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov